TP53 and cancer: On the other hand, this process was suggested to be beneficial for cancer cells seeking a proliferative advantage in specific growth environments, as centrosome amplification in p53-deficient cancer cells can encourage chromosome mis-segregation (Yoshino et al., 2021), a key promoter of genomic heterogeneity.